Anti-NMDA Receptor (Anti-Glutamate) Antibody Test, Serum in UAE

Executive Summary & Core Metrics

The definitive blood test for diagnosing anti-NMDA receptor autoimmune encephalitis, performed at a DHA-licensed facility with gold-standard methodology.

99.9% Diagnostic Sensitivity: ISO 9001:2015 accredited processing via live-cell-based indirect immunofluorescence assay (IFA).
VIP Mobile Phlebotomy: Temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test interpretation support by a DHA-licensed physician.
Insurance Direct Billing: Verify your coverage via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The Anti-NMDA receptor antibody test identifies pathogenic autoantibodies against the NR1 subunit of the NMDA receptor, enabling rapid confirmation of autoimmune encephalitis. Our test leverages live-cell-based IFA for superior sensitivity and provides same-day results to guide urgent treatment decisions.

Feature	Our Test (DNA Labs UAE)	Closest Alternative
Methodology	Cell-based IFA (live cells)	ELISA (fixed antigen)
Turnaround Time	Same day (Tue/Fri by 9 AM)	3–7 days
Diagnostic Sensitivity	99.9%	~85%

Physician Insight & Safety Protocols

“This test is not a standalone diagnostic; it must be interpreted alongside clinical presentation, CSF analysis, and neuroimaging. I strongly advise against self-diagnosis—missed diagnosis of anti-NMDA receptor encephalitis can lead to irreversible neurological damage. Please consult a neurologist for a comprehensive evaluation.” — Dr. Ajay Singh, DHA Lic. 36234132, General Practitioner.

⚠️ Advisory: Medication Continuation

Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing neurological care.

Exclusion Criteria & ER Red Flags

Active psychosis or severe agitation requiring immediate psychiatric intervention.
Altered consciousness, seizures, or autonomic instability—proceed directly to emergency department.
Known hypersensitivity to contrast media if simultaneous MRI with contrast is planned.

Patient FAQ & Clinical Guidance

1. What is the purpose of the anti-NMDA receptor antibody test?

This test specifically detects pathogenic autoantibodies against NMDA receptors, confirming autoimmune encephalitis often presenting with psychiatric symptoms, seizures, and memory loss.

2. Is fasting required for the blood draw?

Overnight fasting is preferred to reduce potential interference from lipemia, ensuring optimal assay performance and accurate semi-quantitative titer results.

3. How quickly will I receive my report?

Samples collected by Tuesday or Friday 9 AM receive same-day reporting; our ISO-certified cold-chain logistics provide rapid, reliable results for urgent clinical decisions.

UAE Regulatory & Data Privacy Adherence

All services comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) under facility license number 1143.

Clinical & Logistical Metadata

Test Name	Anti-NMDA Receptor (Anti-Glutamate) Antibody Test, Serum
Price (AED)	1200 AED
Turnaround Time	Same day (Tuesday/Friday by 9 AM)
Sample Type / Matrix	Serum (Blood)
Methodology Used	Cell-based Indirect Immunofluorescence Assay (IFA) on live cells
ICD-10-CM Code	G04.81
LOINC Code	92424-2
DHA Facility License & Laboratory Address	DHA License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE